Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Recruiting

Phase 1

S-892216-LAIStudy of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Sponsor:

Shionogi

Code:

NCT07093580

Conditions

Healthy Participants

Eligibility Criteria

Sex: Male

Age: 18 - 55

Healthy Volunteers: Accepted

Interventions

S-892216-LAI

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-19. This information was provided to ClinicalTrials.gov by Shionogi on 2025-08-27.